HOME ·

BOAN BIOTECH

BOAN BIOTECH (06955.HK): Masked PD-1/IL-2 Prodrug BA1203 Approved for Clinical Trial in China for Multiple Solid Tumours
Tags：
BOAN BIOTECH06955.HKR&D Progress
2026-09-14
BOAN BIOTECH (06955.HK): Enters into Supplementary Agreement to Finance Lease, Confirming RMB 75 Million Purchase Price Unchanged
Tags：
BOAN BIOTECH06955.HKFinance Lease
2026-09-09
BOAN BIOTECH (06955.HK): IND application for BA2201 (TL1A/IL-23) accepted by CDE
Tags：
BOAN BIOTECH06955.HKClinical Trial
2026-08-26
BOAN BIOTECH(06955.HK): Aflibercept Intravitreal Injection Submitted for Marketing Approval in Brazil for Wet AMD and Diabetic Macular Edema
Tags：
BOAN BIOTECH06955.HKNew Drug Marketing Application
2026-08-05
BOAN BIOTECH(06955.HK): IND Application for BA1203 (Masked PD-1/IL-2 Antibody-Cytokine Prodrug) Accepted by CDE
Tags：
BOAN BIOTECH06955.HKIND application
2026-07-08